Jack Nathan Medical Corp.
JNH.V
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 55.39% | 89.64% | -53.27% | 678.05% | -114.20% |
| Total Depreciation and Amortization | -92.56% | -88.07% | -86.61% | -75.27% | 50.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -80.65% | 31.82% |
| Total Other Non-Cash Items | -99.76% | 84.97% | 114.10% | -8,119.84% | 1,633.80% |
| Change in Net Operating Assets | 1,234.52% | -85.55% | 46.74% | 77.55% | -55.25% |
| Cash from Operations | 300.07% | 89.60% | 46.76% | 27.24% | 9.76% |
| Capital Expenditure | 100.00% | -- | -- | 64.09% | 96.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -- | 428.06% | 96.65% |
| Total Debt Issued | -- | -- | -- | -113.91% | -- |
| Total Debt Repaid | 83.35% | 76.43% | 75.96% | 75.20% | 30.96% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -132.34% | -125.92% |
| Cash from Financing | -102.70% | 82.11% | -102.10% | -123.39% | 159.78% |
| Foreign Exchange rate Adjustments | 447.11% | -180.36% | -735.04% | -3,366.67% | 623.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 622.68% | 85.32% | 5.02% | 184.03% | 79.50% |